Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Tibulizumab (D11127) | [1] Tibulizumab Tibulizumab | [1] Tibulizumab
Tibulizumab
(D11127) 💬 | [2] IL17A IL17A,TNFSF13B 💬 | [8] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 53 53 💬 |
| 2 | Tibulizumab (LY3090106) (D11127) | [1] Tibulizumab Tibulizumab | [1] Tibulizumab
Tibulizumab
(D11127) 💬 | [2] IL17A IL17A,TNFSF13B 💬 | [8] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 53 53 💬 |